Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory? (Q37941886)

25 August 2017

1 reference

title

Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory? (English)

1 reference

25 August 2017

main subject

Muckle-Wells syndrome

1 reference

Simon M Mueller

1

1 reference

25 August 2017

Peter Itin

series ordinal

2

1 reference

25 August 2017

Peter Haeusermann

series ordinal

3

1 reference

25 August 2017

publication date

29 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

223

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

113-118

1 reference

Canakinumab for treatment of cryopyrin-associated periodic syndrome

25 August 2017

cites work

1 reference

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France

21 January 2018

1 reference

Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics

21 January 2018

1 reference

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

21 January 2018

1 reference

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

Neurologic manifestations of the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

Hereditary periodic fever and reactive amyloidosis.

21 January 2018

1 reference

Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement

21 January 2018

1 reference

Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred

21 January 2018

1 reference

Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature

21 January 2018

1 reference

A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference.

21 January 2018

1 reference

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

21 January 2018

1 reference

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

21 January 2018

1 reference

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes

21 January 2018

1 reference

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 January 2018

1 reference

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

21 January 2018

1 reference

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000331580

1 reference

25 August 2017

1 reference